Keywords: Quantitative Imaging, Quantitative Imaging, MR-STAT; Contrast Enhancement Imaging
Motivation: Several concerns have been raised about the harmful effects of gadolinium-based contrast agent (GBCA) usage during MRI exams.
Goal(s): To reduce the GBCA dose in MRI protocols.
Approach: We developed an optimized and fast MR-STAT protocol for “pre- and post-injection” quantitative MRI and applied it to two retrospective simulated patient datasets and one prospective in-vivo scan.
Results: The inferred lesion masks generated by comparing “pre- and post-injection” T1 maps demonstrated that the proposed relaxometry-based method was able to correctly detect the lesions. Furthermore, the performance for the low-dose protocol was comparable to that of the full-dose one.
Impact: The quantification of T1 changes after administering GBCA by using the accelerated MR-STAT protocol potentially enables a substantial reduction in both GBCA dose and acquisition time in clinical protocols.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords